Feinerman Vision · Newport Beach · Transparency

Our Results

Published outcomes, disclosed sample sizes, and the sources behind every number.

Updated August 2026 · Individual results vary

Most practices describe their outcomes with adjectives. We prefer numbers. This page gathers the outcome data behind each procedure we perform: our own published series where we have one, and the peer-reviewed or FDA clinical data for each platform. Where the data is ours, the sample size is disclosed. Where it is not ours, the source is named.

Light Adjustable Lens: Our 2025 Series

In our 2025 series of 137 eyes, outcomes after light treatments were:

MeasureResultCohort
Within 0.50 D of refractive target98%137 eyes, 2025
Seeing 20/20 or better91%137 eyes, 2025

The Light Adjustable Lens is the only intraocular lens whose power can be adjusted after surgery, once your vision is real rather than predicted. More than 300,000 have been implanted worldwide (RxSight, 2026), and in the FDA clinical study, patients who received the lens were twice as likely to achieve 20/20 distance vision at six months without glasses as those who received a standard monofocal. See the full LAL results report.

WaveLight® Plus LASIK: Published Clinical Outcomes

Visual acuity achievedShare of eyesSource
20/20 or better100%Published clinical study
20/16 or better89%Published clinical study
20/12.5 or better50%Published clinical study

Source: He C, Bala C. J Cataract Refract Surg. 2023;49(11):1140-1146.

Dr. Feinerman was the first surgeon in Orange County and greater Los Angeles to perform WaveLight® Plus LASIK following its FDA approval, using INNOVEYES SightMap™ ray-tracing to design each treatment from a 3D model of the individual eye. About the platform.

EVO ICL™: Global Track Record

More than 4 million implantable collamer lenses have been sold worldwide, and among patients studied, the implantable collamer lens carries a 99.4% satisfaction rate. The lens is FDA approved for ages 21 to 60, treating nearsightedness from -3.00 to -20.00 diopters, with or without astigmatism, and it is reversible: it can be removed or exchanged by a surgeon if your needs change. Dr. Feinerman was first in California to implant the Visian ICL after its 2005 FDA approval, with 20+ years of experience with the implantable collamer lens. About EVO ICL.

What Patients Report

Our Newport Beach patients have shared 297 Google reviews, with an average rating of 4.9 stars, and several of the physicians who chose us for their own eyes have shared their experiences on our testimonials page.

How to Read These Numbers

Outcome data describes cohorts, not individuals. Your candidacy, your anatomy, and your goals determine what is realistic for your eyes, which is why every consultation at Feinerman Vision is performed personally by Dr. Feinerman, with imaging from iTrace, Pentacam, IOL Master, and OCT. Results on this page reflect the cohorts and studies described, and individual results vary.

Schedule your consultation with Dr. Feinerman: call (949) 631-4780 or take the candidacy quiz.

This quiz is educational and does not diagnose any condition or guarantee candidacy for any procedure. Candidacy is determined only by a comprehensive evaluation, including corneal imaging and a full eye exam, performed by Gregg Feinerman, MD, FACS. Feinerman Vision · 320 Superior Ave, Suite 390, Newport Beach, CA 92663 · (949) 631-4780 · FeinermanVision.com